Cargando…

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients

Background: Anti-programmed cell death 1 (PD-1) monoclonal antibodies (Abs) unleash an immune response to cancer. However, a disruption of the immune checkpoint function by blocking PD-1/PD-ligand 1(PD-L1) signaling may trigger myasthenia gravis (MG) as a life-threatening immune-related adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saruwatari, Koichi, Sato, Ryo, Nakane, Shunya, Sakata, Shinya, Takamatsu, Koutaro, Jodai, Takayuki, Mito, Remi, Horio, Yuko, Saeki, Sho, Tomita, Yusuke, Sakagami, Takuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407108/ https://www.ncbi.nlm.nih.gov/pubmed/30682845 http://dx.doi.org/10.3390/cancers11020140

Ejemplares similares

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020)

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
por: Sato, Ryo, et al.
Publicado: (2019)

Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors
por: Tomita, Yusuke, et al.
Publicado: (2022)

Clinical application of clustered-AChR for the detection of SNMG
por: Zhao, Guang, et al.
Publicado: (2015)

Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics
por: Migiyama, Yohei, et al.
Publicado: (2021)

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer
por: Imamura, Kosuke, et al.
Publicado: (2022)

A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis
por: Cai, Yu, et al.
Publicado: (2021)

Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy
por: Tamanoi, Daisuke, et al.
Publicado: (2021)

Primary lung sebaceous carcinoma successfully treated with radiotherapy and pembrolizumab: A case report
por: Jodai, Yasumiko, et al.
Publicado: (2022)

A Patient with Fulminant Myasthenia Gravis Is Seropositive for Both AChR and LRP4 Antibodies, Complicated by Autoimmune Polyglandular Syndrome Type 3
por: Inoue, Hiroyasu, et al.
Publicado: (2020)

alpha-Actinin interacts with rapsyn in agrin-stimulated AChR clustering
por: Dobbins, G Clement, et al.
Publicado: (2008)

The Regulation Effect of α7nAChRs and M1AChRs on Inflammation and Immunity in Sepsis
por: Hu, Song, et al.
Publicado: (2021)

PKC and PKA Regulate AChR Dynamics at the Neuromuscular Junction of Living Mice
por: Martinez-Pena y Valenzuela, Isabel, et al.
Publicado: (2013)

Impact of Key Nicotinic AChR Subunits on Post-Stroke Pneumococcal Pneumonia
por: Jagdmann, Sandra, et al.
Publicado: (2020)

HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions
por: Osseni, Alexis, et al.
Publicado: (2020)

AChRs Degeneration at NMJ in Aging-Associated Sarcopenia–A Systematic Review
por: Bao, Zhengyuan, et al.
Publicado: (2020)

Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses
Publicado: (1991)

AChR deficiency due to ε-subunit mutations: two common mutations in the Netherlands
por: Faber, Catharina G., et al.
Publicado: (2009)

Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
por: Zhao, Rui, et al.
Publicado: (2021)

IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation
por: Cao, Michelangelo, et al.
Publicado: (2023)

Local neurotrophic repression of gene transcripts encoding fetal AChRs at rat neuromuscular synapses
Publicado: (1995)

Agrin-induced reorganization of extracellular matrix components on cultured myotubes: relationship to AChR aggregation
Publicado: (1990)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015)

Compromised fidelity of B‐cell tolerance checkpoints in AChR and MuSK myasthenia gravis
por: Lee, Jae‐Yun, et al.
Publicado: (2016)

Expression and Possible Role of Nicotinic Acetylcholine Receptor ε Subunit (AChRe) in Mouse Sperm
por: Makino, Yusei, et al.
Publicado: (2021)

Plasma Myokine Profiles in Patients With AChR- and MuSK-Ab-Positive Myasthenia Gravis
por: Seok, Jo Woon, et al.
Publicado: (2023)

The Clinical Outcome in AChR-Positive Generalized Myasthenia Gravis: A Retrospective Observational Study
por: Ojha, Pawan T., et al.
Publicado: (2023)

gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan
por: Yamakawa, Makoto, et al.
Publicado: (2021)

Temperature-sensitive expression of all-Torpedo and Torpedo-rat hybrid AChR in mammalian muscle cells
Publicado: (1990)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
Publicado: (2015)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
Publicado: (2015)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
por: Saxena, Abhishek, et al.
Publicado: (2017)

Slow‐channel myasthenia due to novel mutation in M2 domain of AChR delta subunit
por: Shen, Xin‐Ming, et al.
Publicado: (2019)

SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
por: Huda, Saif, et al.
Publicado: (2019)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
por: Lupica, Antonino, et al.
Publicado: (2022)

Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
por: Huang, Chao, et al.
Publicado: (2022)

Impaired gating of γ‐ and ε‐AChR respectively causes Escobar syndrome and fast‐channel myasthenia
por: Shen, Xin‐Ming, et al.
Publicado: (2023)

Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment
por: Nakashima, Kei, et al.
Publicado: (2020)

Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy
por: Sakata, Shinya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_si00aufuptkchp7c2cl6r0r7ug